Uncategorized

New Releases from NCBI BookshelfAnti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis [Internet].Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis [Internet].

Leave a Comment / Uncategorized / admin

Proliferative diabetic retinopathy is a major cause of sight loss in people with diabetes, with a high risk of vitreous […]

New Releases from NCBI BookshelfA personalised health intervention to maintain independence in older people with mild frailty: a process evaluation within the HomeHealth RCT [Internet].A personalised health intervention to maintain independence in older people with mild frailty: a process evaluation within the HomeHealth RCT [Internet].

Leave a Comment / Uncategorized / admin

Frailty is common in later life and can lead to adverse health outcomes. Services aimed at preventing decline in early

New Releases from NCBI BookshelfTreosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal).Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal).

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfOlaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer.Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfDurvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer.Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfOlaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer.Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfIRIS Toxicological Review of Formaldehyde (Inhalation) CASRN 50-00-0.IRIS Toxicological Review of Formaldehyde (Inhalation) CASRN 50-00-0.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfFluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema.Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfTalazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations.Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfIvosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments.Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments.

Leave a Comment / Uncategorized / admin

Post Content